Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
IMV Inc
IMVIF
Healthcare
Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:IMVIF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(11)
•••
DaveInvestor59
X
View Profile
View Bullboard History
Comment by
DaveInvestor59
on Aug 11, 2021 5:33pm
RE:Agree
I agree. The biggest joke of all is that I bought IMV at its high yesterday hoping that the combination of news yesterday and the financial report today would keep the stock price going up. Stupid me,
...more
(8)
•••
Will101
X
View Profile
View Bullboard History
Comment by
Will101
on Aug 11, 2021 3:10pm
RE:RE:Falling Share Price
Today it shows how destroyed the company and management of IMV is. Again, just a toy for day traders. Even though the medical results were good, the tsunami of sellers overwelmed the few of us who are
...more
(2)
•••
Breakthorough
X
View Profile
View Bullboard History
Comment by
Breakthorough
on Aug 11, 2021 12:03pm
RE:Falling Share Price
Today it was announced that next results (bladder and MSI-H from the Basket Trial) will be in Q4 2021. Some months before more data... On the other hand, ovarian data are great. NO ONE in this
...more
(38)
•••
Hideaway
X
View Profile
View Bullboard History
Post by
Hideaway
on Aug 11, 2021 11:58am
Falling Share Price
Hard for an investor to understand why we are now down after what appeared to be an encouraging NR.I know day traders can manipulate the price and the Company's track record does nothing to
...more
(38)
•••
Hideaway
X
View Profile
View Bullboard History
Comment by
Hideaway
on Aug 10, 2021 8:20pm
RE:Let's forget about the meme action for a second
Abe,I agree that we had great results.Too bad it was not reflected in today's trading.One of the issues is that IMV Does not have the confidence of investors because of past performance and it has
...more
(0)
•••
abe492
X
View Profile
View Bullboard History
Post by
abe492
on Aug 10, 2021 7:22pm
Let's forget about the meme action for a second
The results I think were fantastic and gives hope for cancer paitents. Ovarian cancer is extremely hard to treat. First, there is a limited amount of drugs that can treat it, second
...more
(2)
•••
europe10
X
View Profile
View Bullboard History
Post by
europe10
on Aug 10, 2021 4:40pm
Agree
Agree, not bad that Ors is out, even though it would have been even better with certain board members leaving as well. It is like a joke shen US childrenlike "investors" run the stock
...more
(8)
•••
Will101
X
View Profile
View Bullboard History
Comment by
Will101
on Aug 10, 2021 2:41pm
RE:RE:OS
It was really time for Fred Ors to go, the way this stock is trading is pathetic. 69M shares traded in the USA, it is now the toy of day traders and Robinhood crowd. They have done a really poor job
...more
(38)
•••
Hideaway
X
View Profile
View Bullboard History
Comment by
Hideaway
on Aug 10, 2021 12:17pm
RE:OS
Breakthrough considering that this is a" last hope" opportunity for these patients,the results are certainly a cause for celebration.The market reaction has been encouraging but with
...more
(2)
•••
Breakthorough
X
View Profile
View Bullboard History
Post by
Breakthorough
on Aug 10, 2021 8:11am
OS
DPX (100% of patients): 19'9 months Mirvetuximab (60% of patients, Follate alpha expression), the reference: 16'6 months. Something to celebrate, really.
(4)
•••
NSFISHER
X
View Profile
View Bullboard History
Comment by
NSFISHER
on Aug 10, 2021 7:56am
RE:top line results out...up +30% on nasdaq as i type this.
When Wells Fargo upgraded IMV with a pt of 14$: "The analysts point to a series of potentially value-generating events in the near term for the vaccine candidate maveropepimut-S, including an
...more
(5)
•••
Mickey2
X
View Profile
View Bullboard History
Post by
Mickey2
on Aug 10, 2021 7:24am
top line results out...up +30% on nasdaq as i type this.
good luck to all.
(10)
•••
prosciutto
X
View Profile
View Bullboard History
Comment by
prosciutto
on Aug 06, 2021 3:51pm
RE:RE:RE:RE:RE:RE:DING DONG
IMV has a long history of ceo duds w very little business accumen. Lets hope they can find someone that puts the company first and has a bit of promotion pizaz.
(2)
•••
pumpbuster2011
X
View Profile
View Bullboard History
Comment by
pumpbuster2011
on Aug 05, 2021 9:01pm
RE:RE:RE:RE:RE:DING DONG
Agreed - Smoke and mirrors to help hide the fact his hand was directly in the cookie jar the whole time.
(1)
•••
gardy
X
View Profile
View Bullboard History
Comment by
gardy
on Aug 05, 2021 8:30pm
RE:RE:RE:RE:DING DONG
His track record with IMV would not suggest up and comer. Glad he is gone, just hope they find someone who can drive this company forward without diluting the shares any further. Jeez! I wonder
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income